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Mushroom intake and risk of epithelial ovarian cancer in southern Chinese women 
 
ABSTRACT 
Objective: To investigate the association between mushroom consumption and risk of 
epithelial ovarian cancer in southern Chinese women. 
Methods: A hospital-based case-control study was undertaken in Guangzhou, Guangdong 
Province, from 2006 to 2008. Participants were 500 incident epithelial ovarian cancer patients 
and 500 controls, with a mean age 59 (SD 6) years. Information on habitual mushroom 
consumption was obtained by face-to-face interview using a validated and reliable food 
frequency questionnaire. Unconditional logistic regression analyses were performed to assess 
the association between mushroom intake and the ovarian cancer risk. 
Results: The ovarian cancer patients consumed less mushrooms (mean 28.48, SD 37.45 
g/day) than controls (mean 30.75, SD 41.85 g/day). Apparent reductions in cancer risk were 
found at high levels of intake, especially for the common white button mushroom with 
adjusted odds ratios 0.68 (95% confidence interval 0.52 to 0.89) for women consuming more 
than 2g per day relative to those below, p = 0.005. Decreases in risk at high levels of intake 
were also observed for serous and mucinous subtypes of epithelial ovarian tumours. 
Conclusions: Intake of mushrooms particularly white button mushroom appeared to be 
inversely associated with the incidence of epithelial ovarian cancer in southern Chinese 
women. 
 





Ovarian cancer is the second most common gynaecological malignancy 
(1)
. Approximately 
90% of ovarian malignancies are epithelial in origin 
(2)
. The disease is generally diagnosed at 
an advanced stage, as the symptoms are vague and non-specific 
(3)
. The incidence of ovarian 
cancer varies substantially across geographical regions, with higher rates generally observed 
in developed countries. For example, the age-standardised rates in China is 3.8 per 100,000 
women, much lower than those of developed countries such as the USA (8.8) and Australia 
(7.7) 
(4)
. The large variations in incidence rates between countries may be attributed to 
differences in dietary and lifestyle habits in ovarian cancer aetiology, besides genetic and 
familial risk factors. 
 
Previous research has reported the protective effects of vegetables, fruit and soy foods 
(5-7)
, 
whereas consumption of meat and preserved foods may contribute to the development of 
ovarian cancer 
(8, 9)
. For thousands of years, mushrooms have been valued for their medicinal 
properties. Some dietary supplements contain mushroom extracts and claim to improve 
immune functions 
(10)
. However, there have been limited epidemiological studies that 
investigated the association between edible mushroom and cancer risk 
(11-16)
, the majority of 
which were conducted on Asian populations. The available evidence suggested that increased 
mushroom intake may reduce the risk of gastric cancer 
(11, 12)
 and breast cancer 
(13-16)
, but 
there is still no published report assessing mushroom intake in relation to ovarian cancer. 
 
China is the biggest mushroom consumption market. An increasing number of urban Chinese 
consumers are replacing meat products with mushrooms 
(17)
. In southern China, several 
species of mushroom are used in local cuisines, including the white button mushroom 
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(Agaricus bisporus), straw mushroom (Volvariella volvacea) and Chinese black (shiitake) 
mushroom, the latter being sun dried and are soaked in water before cooking. In view of the 
lack of epidemiological evidence, the present study investigated the association between 
habitual mushroom consumption and the risk of epithelial ovarian cancer among southern 
Chinese women. The study formed part of a research project assessing the role of dietary and 
lifestyle factors for the prevention of this major disease. 
 
MATERIALS AND METHODS 
Study design and subjects   
A case-control design was used to study risk factors associated with ovarian cancer in the 
Guangdong Province of southern China, between August 2006 and July 2008. Cases and 
controls were recruited from four public hospitals located in Guangzhou: The Overseas 
Hospital (affiliated with Jinan University), Zhujiang Hospital, General Hospital of 
Guangzhou Military Command, and Second Affiliated Hospital of Zhongshan University. 
The cases were incident patients who had been histopathologically diagnosed with epithelial 
ovarian cancer. Controls were recruited from inpatient wards of the Departments of 
Ophthalmology, Orthopedics, Respiratory Disease, Gastroenterology and Physiotherapy. The 
inclusion criteria for all subjects were less than 75 years of age and to have resided in the 
metropolitan Guangzhou area for the past ten years or more. Participants were also excluded 
if the medical staff advised that they were too ill to participate or had severe memory 
impairment that precluded their recall of risk factors.  
 
Potential cases were identified by searching all medical records and laboratory pathology 
reports at the participating hospitals on a daily basis during the recruitment period. The 





. Patients were excluded if a diagnosis of ovarian cancer was not 
histopathologically confirmed as the diagnosis, or if the subject had memory problems 
affecting their recall of past events. A total of 504 cases consecutively recruited from the four 
hospitals were eligible to participate and 500 patients (99.2% consent rate) gave their consent 
to participate and were capable of being interviewed. 
 
During the same period, 512 potential controls satisfying the age and residency criteria were 
identified and were invited to participate. The controls were frequency matched to cases by 
age ( 5 years). Exclusion criteria for controls were: previous diagnosis of ovarian cancer or 
other malignant diseases; a history of bilateral oophorectomy; on a long-term modified diet 
for medical reasons; having memory problems. Potential controls were initially identified 
using the hospital daily census sheets. A selection of wards and patients to be screened was 
made using random numbers each day whenever an excess of control subjects , more than 
could be interviewed, were available. All eligible inpatients had their diagnosis subsequently 
confirmed by histopathological reports to avoid misclassification of the case-control status. 
This systematic selection process was used for the duration of the recruitment period. Twelve 
women who declined the interview or not satisfying the eligibility conditions were later 
excluded, resulting in a final sample of 500 controls (97.6% response) available for analysis. 
No statistically significant differences were found between the two groups in terms of age 
and main demographic variables.    
 
Interview 
Appointments for face-to-face interview at the ward were made after consulting the nursing 
staff to avoid interference with treatment. Whenever possible, subjects were interviewed in 
the presence of their next-of-kin to help in the recall of past dietary habits. All participants 
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were read an information sheet giving details of the study and were assured of confidentiality 
and their right to withdraw at any time without prejudice. They were then asked to give 
formal consent before the interview commenced. Each interview was conducted in either 
Mandarin or the Cantonese dialect and took about 45 minutes to complete. All participants 
were blinded to the study hypothesis. The project protocol was approved by the participating 
hospitals, the doctors-in-charge of the relevant wards, and the Human Research Ethics 
Committee of the researchers’ institution (approval number HR 78/2006).  
 
Questionnaire and exposure measurements 
A structured questionnaire was administered to obtain demographic and lifestyle 
characteristics including age, weight (kg), height (m), education level, smoking status and 
alcohol consumption, as well as reproductive history, hormonal status and heredity. Self-
reported data were cross-checked with medical records whenever possible.  
 
Participants were also requested to estimate the average time they had engaged in physical 
activities using a validated questionnaire 
(19)
. Intensity was classified by the amount of energy 
or effort a person expends in performing the activity. Physical activity at each intensity level 
was quantified in terms of metabolic equivalent tasks (MET)-hours per week, with intensity 
codes 7.5, 6.0 and 4.5 MET assigned to strenuous sports, vigorous work and moderate 
activity, respectively. Total physical activity was then calculated by summing the product of 
the MET scores and the activity duration over the three intensity levels. 
 
Information on habitual food and beverage consumption was obtained using a 125-item semi-
quantitative food frequency questionnaire developed and tested in a southern Chinese 
population 
(20, 21)
. This validated instrument covers commonly consumed foods (including 
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mushrooms) in southern China. Each subject was asked to record in detail the frequency and 
amount of food eaten or drunk. The reference recall period for dietary variables was set at 
five years before diagnosis for cases and five years before interview for controls. The energy 
content of each food or beverage item was obtained from the Chinese food composition 
tables 
(22)
. We then estimated participant’s total energy intake (kcal) by summing the energy 
intake across all of the individual items consumed. 
 
Statistical analysis 
Descriptive statistics were first applied to summarize the sample characteristics. Total 
mushroom intake (g/day) was defined as the sum of daily consumption of white button, straw 
and Chinese black mushrooms. Case and control groups were compared in terms total and 
individual mushrooms intake. Unconditional logistic regression analyses were then 
performed to investigate the effects of habitual mushroom consumption on the ovarian cancer 
risk. Each consumption variable was dichotomized into low and high levels of exposure with 
cutoff points determined based on the distribution of controls, due to their relatively low 
amount of daily intake. To investigate the risk of ovarian cancer by specific histologic 
subtype, we compared selected case subtype to the entire control group using adjusted odds 
ratios (OR) and associated 95% confidence intervals (CI). Confounding variables included in 
the logistic regression models were age at interview (years), age of menarche (years), parity, 
oral contraceptive use (never, ever), body mass index (5 years ago), menopausal status (pre, 
post), education level (none or primary, secondary, vocational or tertiary), tobacco smoking 
(never, ever), alcohol drinking (no, yes), physical activity (MET-hours/week), total energy 
intake (kcal/day), and family history of ovarian or breast cancer (no, yes). These variables 
were either established or plausible risk factors from the literature. All statistical analyses 





Half of the 500 epithelial ovarian tumours were classified as serous (50%), followed by 
mucinous (16%), borderline (13%), and undifferentiated carcinoma (11.8%).  The other 
histologic subtypes (endometrioid, mixed, clear cell, transitional cell, malignant Brenner’s 
tumour) made up the remaining 9.2% of the cases. Table 1 presents the sample characteristics 
by case-control status. The participants were on average 59 (SD 6) years of age and 
predominantly post-menopausal (95%). Most of them had secondary school or above 
education (60%), were non-smokers (97%) and seldom drank alcoholic beverages on a 
regular basis (72%). Very few women (3.5%) had a family history of ovarian or breast 
cancer. However, women with ovarian cancer appeared to have less oral contraceptive use 
and lower parities (p < 0.01) but higher mean body mass index (p < 0.01) than their 
counterparts without the disease. They also tended to be less physically active in daily life (p 
< 0.01). 
 
Table 2 compares habitual mushroom consumption between case and control groups. The 
ovarian cancer patients reported lower total mushroom intake (mean 28.48, SD 37.45 g/day) 
than the control subjects (mean 30.75, SD 41.85 g/day). Indeed, lower levels of consumption 
were observed across all three types of mushroom, but such differences attained statistical 
significance (p < 0.05) only for the white button mushroom. 
 
Table 3 summarizes the results of logistic regression analyses. Apparent reductions in ovarian 
cancer risk were achieved at high levels of total and individual mushroom intake, especially 
for white button mushroom with adjusted OR 0.68 (95% CI 0.52 to 0.89) for women 
consuming more than 2g per day relative to those below, p = 0.005. Decreases in risk at high 
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levels of intake were similarly found among serous and mucinous subtypes of epithelial 
ovarian tumours. Analyses were not performed for other histologic subtypes due to the low 
number of cases available.  
 
DISCUSSION 
The present study provides the first epidemiological report on the association between 
mushroom intake and epithelial ovarian cancer risk. A major strength was the implementation 
of a standardized identification procedure which ensured that ascertainment of cases was 
maximized and complete. To avoid misclassification of the case-control status, we recruited 
only incident patients who had been histopathologically diagnosed with epithelial ovarian 
cancer within the past 12 months. Meanwhile, all controls were carefully screened and 
subsequently confirmed with pathology. A high response rate (98%) was achieved in the 
recruitment of inpatients through assistance by the hospital medical staff. Another strength 
concerned habitual mushroom consumption, which was measured using a validated and 
reliable questionnaire developed for the southern Chinese population. To determine and 
ascertain the effect of mushroom intake, information on confounding factors such as tobacco 
smoking, alcohol drinking and physical activity was also collected. It is possible that some 
ovarian cancer patients may modify their dietary habits since the onset of the disease. 
Therefore, the reference period for habitual mushroom consumption was set at five years 
before diagnosis for cases and five years before interview for controls in order to avoid 
reverse causation. In this study, no participant reported any change in eating habits for 
medical reasons within the past five years. 
 
Our results suggested that mushroom intake at high levels was associated with a reduced risk 
of epithelial ovarian cancer among southern Chinese women, particularly for the common 
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Agaricus bisporus mushroom. Similar inverse associations have been reported for gastric and 
breast cancers 
(11-16)
. Mushrooms are high in fibre, vitamins and minerals such as vitamin B, 
potassium, and phosphorus 
(23)
. They also contain bioactive compounds, including anti-
tumour polysaccharides 
(24)
. Animal studies have reported on the anti-carcinogenic effect of 
various mushroom species. For example, lectins isolated from mushroom could activate 
macrophages and inhibit the growth of implanted cancer cells in mice 
(25)
, while 
phytochemicals present in white button mushroom extracts have been found to inhibit 
aromatase activity and proliferation in breast cancer cell lines 
(26-28)
.  These phytochemicals 
also affect free radical scavenging activity and inhibition of oxidative stress 
(29, 30)
. Other 
potential mechanisms include suppression of DNA synthesis, altering membrane structure 




In this study, Chinese black mushroom and white button mushroom appeared to have their 
respective effect on mucinous and serous subtypes of epithelial ovarian tumours. A high level 
of cholesterol is known to elevate the risk of mucinous ovarian neoplasm 
(31)
. Chinese black 
mushroom contains the cholesterol reducing compound eritadenine 
(32)
, which may protect 
against the development of mucinous tumours. On the other hand, vitamin D, which is 
present in white button mushroom but not in Chinese black mushroom, has been shown to 
inhibit serous ovarian tumours 
(33)
. Nevertheless, further experimental studies are needed to 
understand the biological mechanisms underlying the protective effects of these mushrooms 
against ovarian cancer. 
 
There are several limitations in this study. Firstly, cause-effect relationship between 
mushroom intake and ovarian cancer prevention could not be established due to the inherent 
retrospective study design. Secondly, dietary assessment was based on self-report so that 
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responses from participants would inevitably incur some recall error, even though the recall 
of habitual mushroom consumption should not be affected by the case-control status. 
Therefore, face-to-face interviews were conducted in the presence of next-of-kin to help 
memory recall and to improve the accuracy of their answers. Thirdly, selection bias was 
unavoidable because of voluntary participation, while the hospital-based controls were not 
randomly selected from the community. Nevertheless, the four participating hospitals serve 
the entire catchment region so that our subjects were still representative of the target 
population. Recruitment bias was also minimized by sampling from different hospitals. 
Fourthly, information bias and recall bias were unlikely because all participants were blind to 
the study hypothesis, while the protective effects of mushroom on ovarian cancer have not 
been established. Finally, residual confounding might still exist even after controlling for 
established risk factors in the multivariable logistic regression analyses. There is no evidence 
from the literature supporting consumption of mushroom as a marker of healthy lifestyle 
among southern Chinese women.  
 
In conclusion, a moderate inverse association was found between habitual mushroom intake 
and epithelial ovarian cancer incidence in southern China. Replications in other countries and 





We are grateful to the patients and medical and nursing staff from the participating hospitals 
for their cooperation in the study.  
12 
 









Education level   0.90 
   None/primary 204 (40.8%) 197 (39.4%)  
   Secondary 171 (34.2%) 175 (35.0%)  
   Vocational/tertiary 125 (25.0%) 128 (25.6%)  
Smoking status   0.49 
   Never 481 (96.2%) 485 (97.0%)  
   Ever 19 (3.8%) 15 (3.0%)  
Alcohol drinking   0.16 
   No 352 (70.4%) 372 (74.4%)  
   Yes 148 (29.6%) 128 (25.6%)  
Parity   < 0.01 
   0 8 (1.6%) 14 (2.8%)  
   1 172 (34.4%) 143 (28.6%)  
   2 219 (43.8%) 176 (35.2%)  
   ≥ 3 101 (20.2%) 167 (33.4%)  
Oral contraceptive use   < 0.01 
   Never 417 (83.4%) 380 (76.0%)  
   Ever 83 (16.6%) 120 (24.0%)  
Menopausal status   0.24 
   Pre 28 (5.6%) 20 (4.0%)  
   Post 472 (94.4%) 480 (96.0%)  
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Family history of ovarian or breast cancer   0.39 
   No 480 (96.0%) 485 (97.0%)  
   Yes 20 (4.0%) 15 (3.0%)  
Age at interview (years): mean (SD) 59.07 (5.68) 59.71 (6.46) 0.10 
Age of menarche (years): mean (SD) 14.68 (1.60) 14.70 (1.80) 0.88 




21.70 (2.54) 21.12 (2.28) < 0.01 
Physical activity (MET-hours/week): 
mean (SD) 
16.21 (14.1) 18.84 (13.0) < 0.01 
 
a 
Chi-square or t-test for difference between cases and controls 
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Table 2. Comparison of mushroom consumption between case and control groups 
 
 Cases Controls 
Daily intake (g) All 
(n = 500) 
mean (SD) 
Serous 
(n = 250) 
mean (SD) 
Mucinous 
(n = 80) 
mean (SD) 
 
(n = 500) 
mean (SD) 





































* p < 0.05, ** p < 0.001 for t-test between cases and controls 
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Table 3. Adjusted odds ratios (95% confidence intervals) of epithelial ovarian cancer risk for 
mushroom intake in southern Chinese women 
 Cases Controls 
(n = 500) All (n = 500) Serous (n = 250) Mucinous (n = 80) 
Daily 
intake (g) 

















p = 0.055 
  
p = 0.104 
  
p = 0.238 
 






























p = 0.005 
  
p = 0.006 
  
p = 0.626 
 






























p = 0.180 
  
p = 0.500 
  
p = 0.066 
 
































p = 0.035 
  
p = 0.275 
  
p = 0.002 
 



























 From separate logistic regression models adjusting for age at interview (years), age of 
menarche (years), body mass index (5 years ago, kg/m
2
), physical activity (MET-
hours/week), total energy intake (kcal/day), parity, oral contraceptive use (never, ever), 
menopausal status (pre, post), education level (none/primary, secondary, vocational/tertiary), 
smoking status (never, ever), alcohol drinking (no, yes), and family history of ovarian or 
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